Expression and substrate specificities of human thymidine kinase 1, thymidine kinase 2 and deoxycytidine kinase. 1991

S Eriksson, and B Munch-Petersen, and B Kierdaszuk, and E Arnér
Department of Biochemistry I, Karolinska Institute, Stockholm, Sweden.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D003842 Deoxycytidine Kinase An enzyme that catalyzes reversibly the phosphorylation of deoxycytidine with the formation of a nucleoside diphosphate and deoxycytidine monophosphate. Cytosine arabinoside can also act as an acceptor. All natural nucleoside triphosphates, except deoxycytidine triphosphate, can act as donors. The enzyme is induced by some viruses, particularly the herpes simplex virus (HERPESVIRUS HOMINIS). EC 2.7.1.74. Kinase, Deoxycytidine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D013937 Thymidine Kinase An enzyme that catalyzes the conversion of ATP and thymidine to ADP and thymidine 5'-phosphate. Deoxyuridine can also act as an acceptor and dGTP as a donor. (From Enzyme Nomenclature, 1992) EC 2.7.1.21. Deoxythymidine Kinase,Deoxypyrimidine Kinase,Kinase, Deoxypyrimidine,Kinase, Deoxythymidine,Kinase, Thymidine
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

S Eriksson, and B Munch-Petersen, and B Kierdaszuk, and E Arnér
May 2017, Annals of neurology,
S Eriksson, and B Munch-Petersen, and B Kierdaszuk, and E Arnér
October 1992, Biochemical and biophysical research communications,
S Eriksson, and B Munch-Petersen, and B Kierdaszuk, and E Arnér
January 1992, Biochemical pharmacology,
S Eriksson, and B Munch-Petersen, and B Kierdaszuk, and E Arnér
February 2009, Biochemistry,
S Eriksson, and B Munch-Petersen, and B Kierdaszuk, and E Arnér
January 2020, Nucleosides, nucleotides & nucleic acids,
S Eriksson, and B Munch-Petersen, and B Kierdaszuk, and E Arnér
January 1993, Advances in enzyme regulation,
S Eriksson, and B Munch-Petersen, and B Kierdaszuk, and E Arnér
October 1971, Experimental cell research,
S Eriksson, and B Munch-Petersen, and B Kierdaszuk, and E Arnér
January 1993, Oncology research,
S Eriksson, and B Munch-Petersen, and B Kierdaszuk, and E Arnér
October 2009, The new microbiologica,
Copied contents to your clipboard!